Skip to content

Raw materials at other companies

Gilead Sciences logo
Gilead SciencesGILD
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
BridgeBio Pharma logo
BridgeBio PharmaBBIO
ALN
Alnylam PharmaceuticalsALNY
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsAndSupplies.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s raw materials?
Mirum Pharmaceuticals, Inc. (MIRM) reported raw materials of $2.61M in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s raw materials changed year-over-year?
Mirum Pharmaceuticals, Inc.'s raw materials decreased by 13.7% year-over-year, from $3.03M to $2.61M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s raw materials?
Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s raw materials has grown at a -1.7% compound annual growth rate (CAGR), from $3M to $2.9M.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.